Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines

Christopher Randolph, Robin Hilsabeck, Ainobu Kato, Parampreet Kharbanda, Yu Yuan Li, Daniela Mapelli, Lisa D. Ravdin, Manuel Romero-Gomez, Andrea Stracciari, Karin Weissenborn

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Low-grade or minimal hepatic encephalopathy (MHE) is characterised by relatively mild neurocognitive impairments, and occurs in a substantial percentage of patients with liver disease. The presence of MHE is associated with a significant compromise of quality of life, is predictive of the onset of overt hepatic encephalopathy and is associated with a poorer prognosis for outcome. Early identification and treatment of MHE can improve quality of life and may prevent the onset of overt encephalopathy, but to date, there has been little agreement regarding the optimum method for detecting MHE. The International Society on Hepatic Encephalopathy and Nitrogen Metabolism convened a group of experts for the purpose of reviewing available data and making recommendations for a standardised approach for neuropsychological assessment of patients with liver disease who are at risk of MHE. Specific recommendations are presented, along with a proposed methodology for further refining these assessment procedures through prospective research.

Original languageEnglish (US)
Pages (from-to)629-635
Number of pages7
JournalLiver International
Volume29
Issue number5
DOIs
StatePublished - 2009

Fingerprint

Hepatic Encephalopathy
Practice Guidelines
Liver Diseases
Quality of Life
Brain Diseases
Nitrogen
Research

Keywords

  • Assessment
  • Encephalopathy
  • Hepatic
  • Neuropsychological
  • Outcome
  • Psychometric

ASJC Scopus subject areas

  • Hepatology

Cite this

Randolph, C., Hilsabeck, R., Kato, A., Kharbanda, P., Li, Y. Y., Mapelli, D., ... Weissenborn, K. (2009). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver International, 29(5), 629-635. https://doi.org/10.1111/j.1478-3231.2009.02009.x

Neuropsychological assessment of hepatic encephalopathy : ISHEN practice guidelines. / Randolph, Christopher; Hilsabeck, Robin; Kato, Ainobu; Kharbanda, Parampreet; Li, Yu Yuan; Mapelli, Daniela; Ravdin, Lisa D.; Romero-Gomez, Manuel; Stracciari, Andrea; Weissenborn, Karin.

In: Liver International, Vol. 29, No. 5, 2009, p. 629-635.

Research output: Contribution to journalArticle

Randolph, C, Hilsabeck, R, Kato, A, Kharbanda, P, Li, YY, Mapelli, D, Ravdin, LD, Romero-Gomez, M, Stracciari, A & Weissenborn, K 2009, 'Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines', Liver International, vol. 29, no. 5, pp. 629-635. https://doi.org/10.1111/j.1478-3231.2009.02009.x
Randolph, Christopher ; Hilsabeck, Robin ; Kato, Ainobu ; Kharbanda, Parampreet ; Li, Yu Yuan ; Mapelli, Daniela ; Ravdin, Lisa D. ; Romero-Gomez, Manuel ; Stracciari, Andrea ; Weissenborn, Karin. / Neuropsychological assessment of hepatic encephalopathy : ISHEN practice guidelines. In: Liver International. 2009 ; Vol. 29, No. 5. pp. 629-635.
@article{93deccf843f74ad49d3dfe4ce66e6e48,
title = "Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines",
abstract = "Low-grade or minimal hepatic encephalopathy (MHE) is characterised by relatively mild neurocognitive impairments, and occurs in a substantial percentage of patients with liver disease. The presence of MHE is associated with a significant compromise of quality of life, is predictive of the onset of overt hepatic encephalopathy and is associated with a poorer prognosis for outcome. Early identification and treatment of MHE can improve quality of life and may prevent the onset of overt encephalopathy, but to date, there has been little agreement regarding the optimum method for detecting MHE. The International Society on Hepatic Encephalopathy and Nitrogen Metabolism convened a group of experts for the purpose of reviewing available data and making recommendations for a standardised approach for neuropsychological assessment of patients with liver disease who are at risk of MHE. Specific recommendations are presented, along with a proposed methodology for further refining these assessment procedures through prospective research.",
keywords = "Assessment, Encephalopathy, Hepatic, Neuropsychological, Outcome, Psychometric",
author = "Christopher Randolph and Robin Hilsabeck and Ainobu Kato and Parampreet Kharbanda and Li, {Yu Yuan} and Daniela Mapelli and Ravdin, {Lisa D.} and Manuel Romero-Gomez and Andrea Stracciari and Karin Weissenborn",
year = "2009",
doi = "10.1111/j.1478-3231.2009.02009.x",
language = "English (US)",
volume = "29",
pages = "629--635",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Neuropsychological assessment of hepatic encephalopathy

T2 - ISHEN practice guidelines

AU - Randolph, Christopher

AU - Hilsabeck, Robin

AU - Kato, Ainobu

AU - Kharbanda, Parampreet

AU - Li, Yu Yuan

AU - Mapelli, Daniela

AU - Ravdin, Lisa D.

AU - Romero-Gomez, Manuel

AU - Stracciari, Andrea

AU - Weissenborn, Karin

PY - 2009

Y1 - 2009

N2 - Low-grade or minimal hepatic encephalopathy (MHE) is characterised by relatively mild neurocognitive impairments, and occurs in a substantial percentage of patients with liver disease. The presence of MHE is associated with a significant compromise of quality of life, is predictive of the onset of overt hepatic encephalopathy and is associated with a poorer prognosis for outcome. Early identification and treatment of MHE can improve quality of life and may prevent the onset of overt encephalopathy, but to date, there has been little agreement regarding the optimum method for detecting MHE. The International Society on Hepatic Encephalopathy and Nitrogen Metabolism convened a group of experts for the purpose of reviewing available data and making recommendations for a standardised approach for neuropsychological assessment of patients with liver disease who are at risk of MHE. Specific recommendations are presented, along with a proposed methodology for further refining these assessment procedures through prospective research.

AB - Low-grade or minimal hepatic encephalopathy (MHE) is characterised by relatively mild neurocognitive impairments, and occurs in a substantial percentage of patients with liver disease. The presence of MHE is associated with a significant compromise of quality of life, is predictive of the onset of overt hepatic encephalopathy and is associated with a poorer prognosis for outcome. Early identification and treatment of MHE can improve quality of life and may prevent the onset of overt encephalopathy, but to date, there has been little agreement regarding the optimum method for detecting MHE. The International Society on Hepatic Encephalopathy and Nitrogen Metabolism convened a group of experts for the purpose of reviewing available data and making recommendations for a standardised approach for neuropsychological assessment of patients with liver disease who are at risk of MHE. Specific recommendations are presented, along with a proposed methodology for further refining these assessment procedures through prospective research.

KW - Assessment

KW - Encephalopathy

KW - Hepatic

KW - Neuropsychological

KW - Outcome

KW - Psychometric

UR - http://www.scopus.com/inward/record.url?scp=64749100701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64749100701&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2009.02009.x

DO - 10.1111/j.1478-3231.2009.02009.x

M3 - Article

C2 - 19302444

AN - SCOPUS:64749100701

VL - 29

SP - 629

EP - 635

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 5

ER -